| Patient | Lou Gehrig |
|---|---|
| Date of birth | 1903-06-19 |
| Identifiers | MRN HR-ET018-SYN-TD; SSN (made up) 000-18-6620 |
| Document date | 1939-06-29 |
| Author | Gavin Hollister, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Six weeks after diagnosis: riluzole safety, genetic test result, the ALS clinic plan, mobility, mood, and work. [S]
Mr. Gehrig returns six weeks after the diagnosis, a week after his first full visit to the multidisciplinary ALS clinic, where he saw the physical, occupational and speech therapists, the dietitian, the respiratory therapist and the social worker. He has taken riluzole twice daily; he had mild nausea in the first week, which settled. The genetic panel found no disease-causing variant in SOD1, C9orf72, FUS, TARDBP or the other genes tested. His grip is weaker and he has tripped twice without falling; the clinic measured him for a left ankle-foot orthosis. He has decided to stop playing professionally and plans to say so publicly soon, and he is thinking about work he could do at a desk. He has been sleeping poorly and feels low at times but enjoys time with friends. [S]
| Element | Detail |
|---|---|
| Riluzole | Twice daily; nausea in the first week, settled |
| Genetic testing | No disease-causing variant found |
| Function | Grip weaker; two trips without a fall; orthosis measured |
| Work | Decided to stop playing; considering desk work |
| Mood | Low at times; poor sleep |
| System | Result | Finding |
|---|---|---|
| Neurological | Positive | Weaker grip; left foot catching; cramps at night |
| Ears, nose, mouth, and throat | Negative | No slurred speech or choking |
| Respiratory | Negative | No breathlessness or orthopnea |
| Gastrointestinal | Negative | Nausea gone; appetite good |
| Psychiatric | Positive | Low at times; poor sleep; no thoughts of self-harm |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Riluzole 50 mg oral tablet, one tablet by mouth twice daily, an hour before or two hours after meals | One tablet by mouth every 12 hours on an empty stomach | Oral route | 1939-05-18 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1939-06-29 | Body height | 183 | cm | S |
| 1939-06-29 | Body weight | 88.4 | kg | S |
| 1939-06-29 | Body mass index (BMI) [Ratio] | 26.4 | kg/m2 | S |
| 1939-06-29 | Systolic blood pressure | 120 | mm[Hg] | S |
| 1939-06-29 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1939-06-29 | Heart rate | 72 | /min | S |
| 1939-06-29 | Respiratory rate | 15 | /min | S |
| 1939-06-29 | Body temperature | 36.7 | Cel | S |
| 1939-06-29 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1939-06-29 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 38 | U/L | 7-55 U/L | Normal | S |
| 1939-06-29 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 33 | U/L | 10-40 U/L | Normal | S |
| 1939-06-29 | Forced vital capacity [Volume] Respiratory system | 4.31 | L | >=4.1 L | Normal | S |
| 1939-06-29 | FVC measured/predicted | 84 | % | 80% of predicted or more is normal; noninvasive ventilation is considered below 50% | Normal | S |
| 1939-06-29 | Total score [ALSFRS-R] | 40 | {score} | S | ||
| 1939-06-29 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 8 | {score} | S |
Vital signs recorded on 1939-06-29; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 120/76, pulse 72; weight 88.4 kg |
| Neurological | Hand wasting slightly more marked; grip 4-/5 on both sides; left ankle dorsiflexion 4-/5; fasciculations in the arms and legs; reflexes brisk; tongue normal |
| Gait | Left foot slap; steady with a hand on the rail |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Progressive weakness and loss of coordination for about a year: fumbling with buttons and a bat, tripping on curbs, a fall on the ice in the winter, muscle cramps and twitching in the arms and thighs; no numbness, pain, double vision, or trouble speaking or swallowing. Examination: wasting of the hand muscles (left more than right), fasciculations in both arms and thighs, weakness of grip and of left ankle dorsiflexion, brisk reflexes with spread and a positive Hoffmann sign, normal sensation. Mixed upper and lower motor neuron signs; evaluation for motor neuron disease and its mimics begun, with neuromuscular neurology consultation booked | resolved | confirmed | M62.81 | S — Synthetic presenting problem anchored to his documented decline in 1938 and 1939; superseded by the diagnosis. |
| Amyotrophic lateral sclerosis, limb onset: progressive weakness for about a year with upper and lower motor neuron signs in the cervical and lumbosacral regions, and active and chronic denervation on EMG in the cervical, thoracic and lumbosacral regions with normal sensory nerve conduction; MRI of the brain and cervical spine and blood tests exclude mimics. Meets the Gold Coast criteria and the revised El Escorial category of clinically probable ALS. ALSFRS-R 42 and FVC 88% of predicted at diagnosis. Synthetic modern episode linked to his documented diagnosis | active | confirmed | G12.21 | S — Synthetic modern diagnosis; the documented 1939 diagnosis is the anchor. EMG findings, scores and timing are synthetic. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | ALSFRS-R | Every 2 to 3 months in the multidisciplinary ALS clinic | Completed today | 40 of 48 (42 at diagnosis) |
| Imaging | Seated forced vital capacity | Every 2 to 3 months in the multidisciplinary ALS clinic | Completed today | 4.31 L, 84% of predicted |
| Examination | Maximal inspiratory pressure; supine capacity and overnight oximetry when values fall or symptoms appear | Every 2 to 3 months in the multidisciplinary ALS clinic | Completed today | Maximal inspiratory pressure -80 cmH2O; no orthopnea |
| Examination | Noninvasive ventilation criteria (FVC below 50%, maximal inspiratory pressure weaker than -60 cmH2O, nocturnal desaturation, orthopnea) | Every 2 to 3 months in the multidisciplinary ALS clinic | Not indicated | No criterion met |
| Examination | Weight and BMI (gastrostomy discussion if weight falls 5 to 10% or swallowing is unsafe; place while FVC is above 50%) | Every visit | Completed today | 88.4 kg, 0.9% below diagnosis |
| Examination | Speech and swallowing assessment | Every 2 to 3 months in the multidisciplinary ALS clinic | Completed today | Normal at the clinic speech assessment; voice banking introduced |
| Survey | Depression (PHQ-9) | Every visit | Completed today | PHQ-9 8, mild |
| Examination | Symptoms: cramps, spasticity, saliva, emotional lability, pain | Every visit | Completed today | Night cramps, eased by stretching; no spasticity problems, drooling or emotional lability |
| Examination | Mobility, falls, orthoses and equipment | Every visit | Completed today | Foot drop; orthosis measured; cane advised |
| Laboratory | ALT on riluzole | Monthly for 3 months, then every 3 months | Deferred | Missed: no liver test was drawn at one month because no visit fell then. ALT 38 U/L today, at six weeks, is normal, so no harm resulted. Corrective action: two- and three-month tests booked with the ALS clinic laboratory |
| Laboratory | Genetic testing (SOD1 result decides tofersen) | Offer at diagnosis to every person with ALS | Completed today | No disease-causing variant in SOD1, C9orf72, FUS, TARDBP or the other genes tested; tofersen not indicated |
| Referral | Multidisciplinary ALS clinic | Every 2 to 3 months in the multidisciplinary ALS clinic | Completed today | First full clinic visit last week |
| Self-management | Work, disability benefits and social work | From diagnosis | Completed today | Stopping professional play; exploring desk work and benefits with the social worker |
| Self-management | Advance care planning | Early, then at each change | Due | Planned for the preventive visit, at his choice |
Goal progress:
Guideline basis: Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review) (2009); Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review) (2009); Evidence-based consensus guidelines for ALS genetic testing and counseling (2023); Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS (2022)
Follow-up: Liver tests at two and three months. ALS clinic in about two months, with primary care the same week. Next scheduled visit 1939-08-24: three months after diagnosis: ALSFRS-R, breathing, weight, speech, mobility equipment, and work accommodations. [S]